Inflammatory bowel disease (IBD) is characterized by chronic inflammatory changes of the intestine of unknown origin. One current hypothesis concerning the pathogenesis of IBD is that this disease arises in genetically susceptible individuals as a result of a dysregulated immune response to enteric flora (6) . Association of genetic mutations in the NOD2 gene in patients with Crohn's disease (CD) may affect innate immunity to bacterial lipopolysaccharides in patients with CD, which may contribute to dysregulation of local immune responses (28) . However, the antigens responsible for this dysregulation have not been identified. Luminal bacteria are thought to initiate and perpetuate intestinal inflammation (21) . Mice with genetically disrupted T-cell receptors develop spontaneous chronic colitis, and this condition is associated with autoantibodies and oligoclonal immune response to luminal bacterial antigens (4) . Interestingly, T-cell receptor-deficient mice do not develop colitis under germfree conditions (4), similar to the colitis generated in genetically disrupted cytokine mouse models, which was attenuated or extinguished when animals were kept in germfree conditions (25, 23) . Although oligoclonal expansion of T-cell clones in patients with CD (9) (10) (11) 16 ) may reflect presentation of specific antigens, including those of intestinal flora, to these T cells, identification of disease-specific antigens that are responsible for the activation of T cells has not been performed.
Immunological responses to bacteria and yeast have been observed in patients with IBD. Involvement of tissue-adhesive Escherichia coli in patients with IBD has been reported (5, 22) , and the diagnostic significance of antibody to Saccharomyces cerevisiae in CD has been documented (15, 18) . We have recently identified intestinal class II major histocompatibility molecule (HLA-DR)-bound peptides and found that most antigenic peptides bound in the HLA-DR antigen-presenting cleft were from exogenous intraluminal proteins, especially food antigens and microorganisms, e.g., E. coli, S. cerevisiae, and Caenorhabditis elegans (20) . However, humoral immune responses to nematodes such as C. elegans, which are widespread in nature not only in soil but also in seawater and freshwater, have not been reported. Therefore, we examined the titers of immunoglobulin G (IgG) and IgG subclass anti-C. elegans antibody (ACEA) in sera from patients with IBD. , and all samples were tested simultaneously. Clinical data for the patients with IBD are summarized in Table 1 . Twenty-three patients with UC had been treated with either sulfasalazine (3 to 4.5g/day) or mesalazine (1.5 to 3 g/day) for at least 3 months. Nine patients with UC were treated with prednisolone (5 to 15 mg/day, orally), the dose of which had been gradually reduced from acute-phase treatment. Nineteen patients with CD had been treated with mesalazine (2.25 to 3 g/day) for at least 3 months. Eight patients with CD were being treated with prednisolone (5 to 10 mg/day, orally). Informed consent was obtained from all patients and healthy volunteers before blood samples were taken. Patients with UC who had a daily stool frequency of more than four times or who had rectal bleeding were considered to have active disease. Activity in patients with CD was evaluated by International Organization of Inflammatory Bowel Disease score (8) .
MATERIALS AND METHODS

Subjects
Antigen preparation. C. elegans was a kind gift from M. Ogata, Osaka University. C. elegans was extensively washed with physiological saline and homogenized with 20 mM Tris-150 mM NaCl buffer containing 1% CHAPS {3- This study was approved by the ethics committee, and informed consent was obtained from all patients.
RESULTS
Serum IgG ACEA. The IgG ACEA titer was significantly higher in patients with UC or CD than in controls (Fig. 1 ). Significant differences in ACEA titer were not found by age, gender, or disease activity. Neither small bowel involvement in the patients with CD nor extent of disease in the patients with UC affected IgG ACEA titers. The IgG ACEA titer did not significantly differ between those patients taking corticosteroids and those not doing so. Dietary therapy with an elemental diet and/or polymeric diet did not affect the IgG ACEA titer. Patients with CD taking mesalazine or sulfasalazine had significantly lower IgG ACEA titers than patients with CD not taking these medications (Fig. 2) . The IgG ACEA titer did not differ significantly between patients with UC taking mesalazine or sulfasalazine and those not taking them; 23 of 29 patients with UC were taking either of the drugs. Therefore, a correlation between the use of those drugs and ACEA levels was not found.
IgG subclass ACEA. IgG subclass ELISA revealed significant increases in IgG2 ACEA titers in patients with UC or CD compared with controls (Fig. 3) . The IgG2 ACEA titer was significantly higher in patients with IBD and intestinal Behçet's disease than in controls. The IgG3 ACEA titer was significantly higher in patients with CD than in patients with UC. The IgG3 ACEA titer was significantly higher for CD colitis than for total and left-sided UC and was significantly higher for CD ileitis than for left-sided UC (Fig. 4) . The IgG2 ACEA titer was significantly lower in patients with CD taking either sulfasalazine or mesalazine than in patients not taking those medications (Fig. 5) . 
DISCUSSION
Involvement of intestinal microflora in the pathogenesis of IBD has been demonstrated. In our recent study sequencing intestinal HLA-DR-bound antigenic peptides, most antigenic peptides bound in the HLA-DR groove were from exogenous intraluminal proteins, especially food antigens and microorganisms, e.g., E. coli, S. cerevisiae, and C. elegans (20) . Tabaqchali et al. (27) reported increased antibody titers against E. coli in patients with CD. Intestinal E. coli strains isolated from patients with IBD are more frequently adhesive than intestinal E. coli isolated from controls or patients with infectious colitis (5, 22) . Such adhesive E. coli disrupts the intestinal barrier by synthesizing an ␣-hemolysin (7). Hence, adhesive E. coli may cross the intestinal barrier, translocate into mesenteric lymph nodes, and generate disturbed immune responses.
Although increased anti-S. cerevisiae antibody (ASCA) is characteristic of patients with CD (15), the etiological role of S. cerevisiae in this disease is still unknown. Differences in elevations of IgG subclass ASCA were found between patients with IBD and those with intestinal Behçet's disease (19) , which may reflect differences in pathways of immunological stimulation between those patient groups. Exclusion of yeast from the diet may help maintain quiescence in patients with CD (2), and perhaps it is not the pathogenicity of S. cerevisiae but its crossreactivity with various antigens generated from altered immune regulation in patients that plays a role in the pathogenesis of CD.
The elevation of serum ACEA levels in patients with IBD is reported here for the first time. C. elegans is a nematode that is widespread in soil and elsewhere in the natural world, and antigens from this worm can be incidentally ingested orally as native proteins or digested substances. Both ingested S. cerevisiae and C. elegans antigens may invade the intestinal mucosa through the disrupted intestinal barrier and are phagocytosed by intestinal antigen-processing cells. As a consequence, B cells are sensitized to become plasma cells to secrete IgG antibodies against S. cerevisiae and C. elegans. Age, sex, disease activity, small bowel involvement in patients with CD, and extent of disease in patients with UC each had no effect on the IgG ACEA titer in the present study.
Elevation of IgG4 ASCA levels in patients with IBD reflects (2), while elevation of IgG2 antibody to C. elegans may reflect a Th1 response to this antigen (26) . The mechanism of induction of diverse IgG subclass reactivities against different antigens such as S. cerevisiae and C. elegans is not known, but differences in accessory signals might contribute to such diversity. The significantly higher IgG3 ACEA titer in patients with CD than in those with UC (Fig. 4) was due to the higher IgG3 ACEA titer in Crohn's colitis than in total and left-sided UC (Fig. 5) . Although IgG3 antibody tends to react to protein antigens in a T-cell-dependent manner and possesses strong complement-binding activity, IgG2 antibody tends to react to carbohydrate and polysaccharide antigens in a T-cell-independent manner and has poor or no complement-binding activity (26) . Serum IgG4 elevation is often associated with the chronic inflammatory state (26) , and IgG4 subclass antibody is predominant among serum anticolon antibodies in patients with UC (17) . Although IgG1 and IgG2 are the predominant subclasses of perinuclear-antineutrophil cytoplasmic antibody, IgG4 predominates in vasculitis-associated antineutrophil cytoplasmic antibody (1). IgG2 antipancreatic antibody was found to be the predominant IgG subclass in patients with CD (24) . Elevation of IgG4 ASCA in patients with IBD may reflect chronic immunological reactivity to dietary antigens (19) , whereas IgG2 elevation in ACEA may reflect a unique humoral immune response against nematodes, perhaps to carbohydrate and polysaccharide antigens.
Dietary therapy and corticosteroid administration did not affect the ACEA titer in patients with IBD, and patients with CD treated with mesalazine or sulfasalazine had significantly lower IgG and IgG2 ACEA titers than patients with CD who were not taking these drugs, a finding also obtained for ASCA titers in patients with CD (18) . Significance might not have been obtained for the patients with UC because most patients with UC were taking either sulfasalazine or mesalazine. Since patients with CD taking mesalazine did not have lower total IgG concentrations in serum than patients with CD not taking mesalazine (18) , oral mesalazine or sulfasalazine administration may suppress local IgG production against C. elegans at the intestinal level, as observed in the ASCA reaction (18) .
Disruption of epithelial barrier may be involved in the pathogenesis of ASCA or ACEA generation in patients with IBD; however, NOD2 gene mutation is not involved in such dysregulation, because of the absence of the NOD2 mutation in Japanese patients with CD (12, 30) . Alterations in innate mucosal immunological factors such as defensins (14, 29) and Toll-like receptors (6) may be involved in disrupted innate immunity and should be further studied. Polyclonal stimuli by lipopolysaccharide via Toll-like receptor 4 in addition to stimuli by bacterial unmethylated single-stranded DNA motifs via Toll-like receptor 9 or T-cell bystander help may activate memory B cells to produce ACEA (3), perhaps as a result of altered immune responses in IBD.
In conclusion, exogenous antigens are processed by human intestinal antigen presentation to increase the humoral immune reaction, and a variety of dysregulated immune responses to intraluminal antigens may play roles in the pathogenesis of IBD.
